Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
- Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the real world.